Why Alnylam Pharmaceuticals Stock Was Soaring on Monday

Several positive new analyst notes were the tailwinds pushing the stock of Alnylam Pharmaceuticals (NASDAQ: ALNY) higher on Tuesday. The first day of the holiday-shortened trading week saw Alnylam's share price floating more than 6% higher in late-session trading. Of these analyses, the one authored by Ilya Zubkov of Freedom Capital Markets appeared to have the greatest impact on Alnylam stock. The pundit upgraded his recommendation on the company to buy from his previous hold, although he lowered his price target on the biotech (to $410 per share from $470). Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool